Top News
Home >> Marketplace Archives >> Beckman introduces Access Sensitive Estradiol

Beckman introduces Access Sensitive Estradiol

Print Friendly, PDF & Email


June 2018—Beckman Coulter Diagnostics launched its Access Sensitive Estradiol in the U.S. and in the majority of worldwide markets. The assay aims to help laboratories deliver more accurate results for patients seeking answers to reproductive health questions. It has a broad measuring range, surpassing clinical decision limits for in vitro fertilization hyper responders. This may allow laboratories to report accurate patient results while avoiding costly dilutions of samples from patients undergoing IVF. The Access Sensitive Estradiol is the only assay in the market with published pediatric reference ranges, according to a press release from the company. It is for use on the company’s immunoassay systems, including the Access 2, DxI 600, and DxI 800.

Beckman Coulter Diagnostics, 714-993-5321


Check Also

FDA-cleared Access AMH immunoassay, 3/18

March 2018—Beckman Coulter Diagnostics announced FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic use. This test aids health care providers in the assessment of a woman’s ovarian reserve and helps guide the clinical management of women struggling with infertility or planning to become pregnant later in life.